Geographical and temporal variations in availability of national price negotiated novel anticancer drugs: a spatial statistical study based on two cross-sectional datasets in China

Geographical and temporal variations in availability of national price negotiated novel anticancer drugs: a spatial statistical study based on two cross-sectional datasets in China

ObjectiveThe National Drug Price Negotiation (NDPN) has significantly reduced the prices and improved the nationwide availability of novel anticancer drugs (NADs) in China. However, geographical disparities in their availability remain concerning. This study aims to assess these spatial variations a...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ziqi Zhao, Shengwei Zhang, Tao Zheng, Ming Hu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Pharmacology
Subjects:	drug availability health disparities and equity GIS and spatial statistics novel anticancer drugs Retrospective databases
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1604008/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Impact of the National Drug Price Negotiation policy on the price, usage, and affordability of anticancer medicines in Shandong Province, China
by: Yaqun Sun, et al.
Published: (2025-01-01)

Utilization and Determinants of Anticancer Drugs Under China&rsquo;s National Drug Price Negotiation Policy
by: Tuo B, et al.
Published: (2025-07-01)

A survey of availability, price, and affordability of innovative negotiated anticancer medicines: a retrospective study in Jiangsu Province, eastern China
by: Rui Ma, et al.
Published: (2025-07-01)

Dynamics of prices and consumption of anticancer drugs in Russia after their generics and biosimilars became available
by: F. V. Gorkavenko, et al.
Published: (2019-07-01)

Impacts of National Reimbursement Drug Price Negotiation on drug accessibility, utilization, and cost in China: a systematic review
by: Zheng Zhu, et al.
Published: (2025-02-01)

Anticancer drug synergy prediction based on CatBoost
by: Changheng Li, et al.
Published: (2025-05-01)

Pattern of adverse drug reactions to anticancer drugs: A quantitative and qualitative analysis
by: Shruti Singh, et al.
Published: (2017-01-01)

Dynamics of anticancer drug use in Russian hospitals: a five-year retrospective analysis
by: J. A. Agafonova, et al.
Published: (2025-02-01)

A Comprehensive Overview of US-FDA-Approved Anticancer Drugs and Biologics in 2023: An Observational Study
by: Ajay Kumar Shukla, et al.
Published: (2025-01-01)

Prenylated Chalcones as Anticancer Agents Against Castration-Resistant Prostate Cancer
by: Marcos Morales-Reyna, et al.
Published: (2025-06-01)

Editorial: Five-membered ring heterocyclic compounds as anticancer drug candidates
by: Arif Mermer, et al.
Published: (2025-04-01)

Combined Graphene Oxide with 2-Methoxyestradiol for Effective Anticancer Therapy in-vitro Model
by: Uzdrowska K, et al.
Published: (2025-01-01)

A convergent fabrication of programmed pH/reduction-responsive nanoparticles for efficient dual anticancer drugs delivery for ovarian cancer treatment
by: Haiyan Zhang, et al.
Published: (2023-12-01)

PEGylated Nanoliposomes Encapsulated with Anticancer Drugs for Breast and Prostate Cancer Therapy: An Update
by: Sijongesonke Peter, et al.
Published: (2025-02-01)

Evaluation the anticancer and biological activity by new amide compound of trimethoprim with some of its complexes
by: Alaa Abdullah Majeed, et al.
Published: (2024-01-01)

InterPAD is a database of drug-drug interaction between phytochemicals and anticancer drugs
by: Aili Zhang, et al.
Published: (2025-07-01)

Efficacy of Off-Label Use of Anticancer Drugs in Oncology
by: E. V. Karabina, et al.
Published: (2023-07-01)

Optimizing nation-wide locations of dialysis centers: a geographic information system-based approach to improve healthcare accessibility and availability
by: Hanna Schroeder, et al.
Published: (2025-07-01)

ADMINISTRATIVE AND ORGANIZATIONAL ASPECTS OF FUNCTIONING OF THE SYSTEM OF AVAILABILITY NARCOTIC AND PSYCHOTROPIC MEDICINAL PREPARATIONS FOR PATIENTS WHO NEED THEM
by: I. A. Kaminskaya, et al.
Published: (2017-03-01)

Analysis of the availability of bronchodilators and anti-inflammatory drugs for patients with chronic obstructive pulmonary disease
by: E. A. Orlova, et al.
Published: (2024-05-01)

Ferrocene-Based Hybrid Drugs as Potential Anticancer and Antibacterial Therapeutic Agents for Incorporation into Nanocarriers: In Silico, In Vitro, Molecular Docking Evaluations
by: Sijongesonke Peter, et al.
Published: (2025-05-01)

Chitosan nanoparticle delivery systems: An effective approach to enhancing efficacy and safety of anticancer drugs
by: Anil Kumar Grewal, et al.
Published: (2024-12-01)

Analysis of the availability and affordability of pharmaceuticals for children in need of palliative care
by: D. M. Medvedeva, et al.
Published: (2021-07-01)

Microbiome Integrity Enhances the Efficacy and Safety of Anticancer Drug
by: Alice N. Mafe, et al.
Published: (2025-02-01)

Insights into the Currently Available Drugs and Investigational Compounds Against RSV with a Focus on Their Drug-Resistance Profiles
by: Alessia Magnapera, et al.
Published: (2025-05-01)

Marine natural products as a source of novel anticancer drugs: an updated review (2019–2023)
by: Hesham R. El-Seedi, et al.
Published: (2025-01-01)

Using publicly available flight data to analyze health disparities in aeromedical retrieval
by: Dylana Moore, et al.
Published: (2020-08-01)

Anticancer properties of beta-caryophyllene and d-limonene terpenes: A review
by: Ololade S. Gbadebo, et al.
Published: (2025-04-01)

Anticancer properties of 1,2,4-triazole derivatives (literature review)
by: I. V. Bushuieva, et al.
Published: (2024-06-01)

Comparative study of β-cyclodextrin derivatives with amlodipine inclusion complexes for enhanced solubility, drug release, and anticancer activity
by: Sonaimuthu Mohandoss, et al.
Published: (2025-12-01)

Substituted 1,4-naphthoquinones for potential anticancer therapeutics: In vitro cytotoxic effects and QSAR-guided design of new analogs
by: Veda Prachayasittikul, et al.
Published: (2025-01-01)

Scientific summarizing of the results of expert evaluation of anticancer drugs for the treatment of gastric and colorectal cancer
by: A. S. Nemchenko, et al.
Published: (2013-10-01)

Immunohistochemistry for Assessing Toxicity and Mechanism of Action of Anticancer Drugs During Preclinical Trials. Part II. Cell Death, Vasculogenesis and Angiogenesis
by: M. A. Akimenko, et al.
Published: (2024-06-01)

Electricity availability and access for economic opportunities: A disaggregated analysis of gender gaps and implications for pro-poor growth
by: Abiola John Asaleye, et al.
Published: (2025-05-01)

A DNA/HDAC dual‐targeting drug CY190602 with significantly enhanced anticancer potency
by: Chuan Liu, et al.
Published: (2015-03-01)

Atom bond connectivity index for graph with self-loops and its application to structure property relationships in anticancer drugs
by: B. Sharath, et al.
Published: (2025-07-01)

Estimating genotoxic effects of anticancer drugs using cytokinesis-block micronucleus assay on human lymphocytes
by: V. I. Minina, et al.
Published: (2019-09-01)

Regional aspects of availability of expectorants and antitussive drugs
by: V. М. Timiryanova, et al.
Published: (2025-02-01)

Effect of using L_arginine in reducing the heart toxicity produced from use Doxorubicin anticancer drug on some hormones in the experimental male rabbits
by: Abeer Talib A. H, et al.
Published: (2023-02-01)

Nanotechnology-based drug delivery system for the diagnosis and treatment of ovarian cancer
by: Rajeswari Saripilli, et al.
Published: (2025-03-01)